Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Revolution Medicines, Inc. (RVMD) had Debt to Capital Ratio of 0.12 for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-247.79M |
|
-- |
|
-- |
|
$264.71M |
|
$-264.71M |
|
$16.93M |
|
$-247.79M |
|
$-247.79M |
|
$-247.79M |
|
$-247.79M |
|
$-247.79M |
|
$-247.79M |
|
$-264.71M |
|
$-268.65M |
|
188.58M |
|
188.58M |
|
$-1.31 |
|
$-1.31 |
|
| Balance Sheet Financials | |
$2.18B |
|
$33.05M |
|
$253.13M |
|
$2.43B |
|
$184.53M |
|
$245.08M |
|
$379.67M |
|
$564.20M |
|
$1.87B |
|
$1.79B |
|
$1.87B |
|
186.90M |
|
| Cash Flow Statement Financials | |
$-416.19M |
|
$18.33M |
|
$257.46M |
|
$546.76M |
|
$406.35M |
|
$-140.41M |
|
$53.91M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.79 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.12 |
0.13 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-426.91M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-13.28% |
|
-13.81% |
|
-10.20% |
|
-11.74% |
|
$9.98 |
|
$-2.26 |
|
$-2.21 |
|